XYZ Biotech: A Fictional Business Development Case Utilizing Quantitative Tools to Evaluate a New Antibody-Drug-Conjugate Opportunity for Metastatic Breast Cancer. AJM. 2023;23(5). Accessed March 16, 2026. https://articlearchives.co/index.php/AJM/article/view/6109